Immune Function and the Progression to T1D
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT05899439
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- blood draw — OTHERa peripheral blood draw
Study Details
To elucidate the mechanisms by which type 1 diabetes-associated genes; IFIH1, TYK2, IKZF4, as well as total genetic risk, impart functional immunoregulatory abnormalities that result in expansion of self-reactive adaptive immune cells, defective regulatory/effector mechanisms in T cells, inflammatory antigen presenting cells, and abnormal immune function in T cells and B cells.
Key Dates
- Start date
- Jan 1, 2005
- Status verified
- Apr 2026
- Primary completion
- Jan 1, 2085
- Completion
- Jan 1, 2085
Study Design
- Enrollment
- 2,800 participants (estimated)
Arms
- Arm: Subjects with diabetes age 0 to 100 yearsPeople who have not been diagnosed with type 1 diabetes
- Arm: Subjects with type 1 diabetes age 0 to 100 yearsPeople who have been diagnosed with type 1 diabetes
Primary Outcome Measure
the number of participants who become at risk for development of type 1 diabetes [ Time Frame: through study completion, up to 25 years ]
Central Contacts
- Jennifer L Hosford, MPH352-294-5759
- Kieran McGrail(352) 273-9299
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kieran McGrail | Gainesville | Florida | 32610 | Todd Brusko, PhD (PRINCIPAL_INVESTIGATOR) |
| The Ohio State University | Columbus | Ohio | 43210 | |
| Baylor College of Medicine, Center for Research Advancement - Texas Children's Hospital | Houston | Texas | 77030 |
Find similar trials in Gainesville, FL
By condition
By specialty
Related Studies
- Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age FamiliesRecruiting · Nemours Children's Clinic · Jacksonville, Florida
- Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 DiabetesPHASE1/PHASE2 · Recruiting · Creative Medical Technology Holdings Inc · Miami, Florida
- EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 DiabetesRecruiting · Baylor College of Medicine · Houston, Texas
- PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early LifeRecruiting · University of Colorado, Denver · Aurora, Colorado